UC-Care

UC-Care develops innovative, fully automated end-to-end solutions for prostate cancer diagnosis and treatment, specifically MRI-ultrasound fusion-guided biopsy and focal therapy procedures. The company's core offering integrates real-time patient motion compensation and automated image processing to enable precise lesion targeting and specimen management. UC-Care's solutions—including the Navigo 4D fusion navigation system, SmartBx biopsy management platform, and FusionStudio DICOM contouring software—are designed to adapt seamlessly to existing clinical workflows in physician practices, ASCs, and hospital settings. The technology delivers improved cancer detection rates (25% increase documented), maintains diagnostic precision despite patient movement, and provides cost-effective fusion-guided biopsy capabilities previously limited to specialized centers. Products are developed with deep understanding of physician and technician realities to minimize workflow disruption while maximizing procedural accuracy and reimbursement alignment.